565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)

A.J. ten Tije; C. Seynaeve; J.H. Schornagel; J.C. Pouget; B. Laffranchi; G. Blanchot; J. Lieverst; J. ter Steg; J. Verweij; J.H.M. Schellens

doi:10.1016/s1359-6349(03)90597-0

565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)

A.J. ten Tije, C. Seynaeve, J.H. Schornagel, J.C. Pouget, B. Laffranchi, G. Blanchot, J. Lieverst, J. ter Steg, J. Verweij, J.H.M. Schellens

Research output: Contribution to journal › Article › peer-review

Original language	Dutch
Pages (from-to)	S171
Journal	European Journal of Cancer Supplements
Volume	1
Issue number	5
DOIs	https://doi.org/10.1016/s1359-6349(03)90597-0
Publication status	Published - Sept 2003

Access to Document

10.1016/s1359-6349(03)90597-0

Cite this

ten Tije, A. J., Seynaeve, C., Schornagel, J. H., Pouget, J. C., Laffranchi, B., Blanchot, G., Lieverst, J., ter Steg, J., Verweij, J., & Schellens, J. H. M. (2003). 565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC). European Journal of Cancer Supplements, 1(5), S171. https://doi.org/10.1016/s1359-6349(03)90597-0

@article{9a323d0de448401fa3bccad305870c5a,

title = "565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)",

author = "{ten Tije}, A.J. and C. Seynaeve and J.H. Schornagel and J.C. Pouget and B. Laffranchi and G. Blanchot and J. Lieverst and {ter Steg}, J. and J. Verweij and J.H.M. Schellens",

year = "2003",

month = sep,

doi = "10.1016/s1359-6349(03)90597-0",

language = "Nederlands",

volume = "1",

pages = "S171",

journal = "European Journal of Cancer Supplements",

number = "5",

}

ten Tije, AJ, Seynaeve, C, Schornagel, JH, Pouget, JC, Laffranchi, B, Blanchot, G, Lieverst, J, ter Steg, J, Verweij, J & Schellens, JHM 2003, '565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)', European Journal of Cancer Supplements, vol. 1, no. 5, pp. S171. https://doi.org/10.1016/s1359-6349(03)90597-0

TY - JOUR

T1 - 565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)

AU - ten Tije, A.J.

AU - Seynaeve, C.

AU - Schornagel, J.H.

AU - Pouget, J.C.

AU - Laffranchi, B.

AU - Blanchot, G.

AU - Lieverst, J.

AU - ter Steg, J.

AU - Verweij, J.

AU - Schellens, J.H.M.

PY - 2003/9

Y1 - 2003/9

UR - https://www.mendeley.com/catalogue/5fce3fa5-d375-3e86-8a40-78f654673e82/

U2 - 10.1016/s1359-6349(03)90597-0

DO - 10.1016/s1359-6349(03)90597-0

M3 - Artikel

VL - 1

SP - S171

JO - European Journal of Cancer Supplements

JF - European Journal of Cancer Supplements

IS - 5

ER -